US Patent

US10449184 — Pharmaceutical compositions of therapeutically active compounds

Formulation · Assigned to Agios Pharmaceuticals Inc · Expires 2035-03-13 · 9y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical compositions of therapeutically active compounds for treating cancer.

USPTO Abstract

Provided are compounds and pharmaceutical compositions useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound or pharmaceutical composition described herein.

Drugs covered by this patent

Patent Metadata

Patent number
US10449184
Jurisdiction
US
Classification
Formulation
Expires
2035-03-13
Drug substance claim
No
Drug product claim
Yes
Assignee
Agios Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.